Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (309)	2/19/1997 8:19:00 AM
From: Pete Holm	of 6136

Speaking of Phase III trials. Roche is involved with AGPH, but they are also working with a company called Protein Design (PDLI). Yesterday, Roche announced that PDLI completed it's Phase III on their anti-rejection drugs for transplants. Filing with the FDA can't be too far away. Of what I read, it looked pretty good (1/10th the number of fatalities compared to the standard regimen. Anybody know anything about this company?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next